Join SHARE in spreading what real survivors wish people knew about ovarian cancer during ovarian cancer awareness month 2018!

The American Cancer Society estimates one in 78 women will be diagnosed with ovarian cancer in their lifetime.

Runners and walkers from around the city gathered at Flushing Meadows Park on Sunday, June 4, for the We Run for Hope 5K/10K Run and Walk. This event, held annually on National Cancer Survivors Day, is a great opportunity to support women with breast or ovarian cancer while also staying fit and active.

Avastin is now approved for ten distinct uses across six different types of cancer in the United States.

SOUTH SAN FRANCISCO, Calif. – June 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection.

By Annie Ellis
Last month I attended the 2018 annual meeting of the Society of Gynecologic Oncology (SGO).  I was a bit sentimental because it was the 10th anniversary of attending for the first time as part of SHARE's 2008 Survivorship Presentation.

What a difference 10 years makes! In 2008 I walked in practically bald and wearing teal from head to toe.

On May 8, people around the world are gathering to support awareness of ovarian cancer. Join SHARE by following us on Facebook, Twitter, and Instagram, where we’ll be posting about signs, symptoms, and stories you can share with the women in your life.

SHARE is saddened by the recent death of Martha Solonche, a pioneer of our ovarian program.

April is National Volunteer Appreciation Month, and SHARE hosted its annual volunteer party to show how much we appreciate the incredible commitment of our volunteers. It was another great gathering with a raffle, food, music, and of course, amazing company.

Recently SHARE was joined by a circle of its friends and supporters at the historic Italian heritage club Tiro A Segno for an evening of food, drink, and learning about SHARE’s impact on women in the New York City area and beyond.

SHARE recently attended the National Comprehensive Cancer Network Conference in Orlando, Florida. The annual conference, now in its 23rd year, aims to improve the quality, effectiveness, and efficiency of cancer care and attracts many oncologists and healthcare professionals.

By Annie Ellis
As I prepare to attend the 2018 annual meeting of the Society of Gynecologic Oncology (SGO), I’ve been thinking about the first time I attended in 2008 along with a group of survivors led by Linda Koteen, SHARE’s Ovarian Program Director at the time.